CHANJET (01588): Re-elect Yang Yuchun as Executive Director
Changtian Technology (01588) announced that the re-election of the following individuals as directors of the sixth board of directors has been formally approved by shareholders at the extraordinary general meeting, with a term of three years starting from the date of the extraordinary general meeting: (i) the re-election of Mr. Wang Wenjing and Mr. Wu Zhengping as non-executive directors of the sixth board of directors; (ii) the re-election of Mr. Yang Yuchun as an executive director of the sixth board of directors; and (iii) the re-election of Mr. Liu Junhui, Ms. Wu Xiaoqing, and Mr. Cui Qiang as independent non-executive directors of the sixth board of directors.
CHANJET (01588) announced that the re-election of the following individuals to the sixth board of directors has been formally approved by shareholders at the extraordinary general meeting, with a term of three years starting from the date of the extraordinary general meeting: (i) the re-election of Mr. Wang Wenjing and Mr. Wu Zhengping as non-executive directors of the sixth board of directors; (ii) the re-election of Mr. Yang Yuchun as an executive director of the sixth board of directors; and (iii) the re-election of Mr. Liu Junhui, Ms. Wu Xiaoqing, and Mr. Cui Qiang as independent non-executive directors of the sixth board of directors.
The re-election of the following individuals to the sixth supervisory board has been formally approved by shareholders at the extraordinary general meeting, with a term of three years starting from the date of the extraordinary general meeting: (i) the re-election of Mr. Guo Xinping and Mr. Li Weimin as shareholder representative supervisors of the sixth supervisory board; and (ii) the re-election of Mr. Ruan Guangli and Mr. Ma Yongyi as independent supervisors of the sixth supervisory board.
Related Articles

Great Wall Motor (02333) spent approximately HKD 2.2038 million to repurchase 289,000 shares on September 8.

Guangzhou Baiyunshan Pharmaceutical Holdings (00874): Guangzhou Baiyunshan Pharmaceutical Holdings Bio has received the Macao Traditional Medicine Registration Certificate.

CSPC PHARMA (01093): The chemical innovative drug SYH2083 eye drops has received clinical trial approval in China.
Great Wall Motor (02333) spent approximately HKD 2.2038 million to repurchase 289,000 shares on September 8.

Guangzhou Baiyunshan Pharmaceutical Holdings (00874): Guangzhou Baiyunshan Pharmaceutical Holdings Bio has received the Macao Traditional Medicine Registration Certificate.

CSPC PHARMA (01093): The chemical innovative drug SYH2083 eye drops has received clinical trial approval in China.

RECOMMEND





